Martin Ingelsson

Martin Ingelsson

Company: Tanz Centre for Research In Neurodegenerative Diseases, University of Toronto

Job title: Professor & Clinician Scientist

Seminars:

CRISPR/Cas9 as a Novel Gene Therapy Tool for Dominantly Inherited Forms of Neurodegenerative Disorders 12:00 pm

Cell model based assessment of CRISPR/Cas9 as treatment of familial Alzheimer’s disease and Parkinson’s disease Mouse model based assessment of CRISPR/Cas9 as treatment of familial Alzheimer’s disease and Parkinson’s disease Challenges ahead before CRISPR/Cas9 can be assessed in clinical trials on patients with neurodegenerative disordersRead more

day: Day Two: Track A AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.